1,2-dihydroxy-1,2-dihydronaphthalene has been researched along with Muscular Dystrophy, Duchenne in 1 studies
1,2-dihydroxy-1,2-dihydronaphthalene: naphthalene metabolite; RN given refers to cpd without isomeric designation
1,2-dihydronaphthalene-1,2-diol : A member of the class of naphthalenediols that is 1,2-dihydronaphthalene substituted by hydroxy groups at positions 1 and 2 respectively.
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatzopoulou, M | 1 |
| Claridge, TDW | 1 |
| Davies, KE | 1 |
| Davies, SG | 1 |
| Elsey, DJ | 1 |
| Emer, E | 1 |
| Fletcher, AM | 1 |
| Harriman, S | 1 |
| Robinson, N | 1 |
| Rowley, JA | 1 |
| Russell, AJ | 1 |
| Tinsley, JM | 1 |
| Weaver, R | 1 |
| Wilkinson, IVL | 1 |
| Willis, NJ | 1 |
| Wilson, FX | 1 |
| Wynne, GM | 1 |
1 other study available for 1,2-dihydroxy-1,2-dihydronaphthalene and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzoxazoles; Humans; Liver; Metabolic Networks and Pathways | 2020 |